Enhabit (NYSE:EHAB) Given “Market Perform” Rating at Leerink Partners

Leerink Partners reissued their market perform rating on shares of Enhabit (NYSE:EHAB) in a report published on Tuesday morning,Benzinga reports. The firm currently has a $8.00 price objective on the stock, down from their prior price objective of $8.50.

Enhabit Stock Performance

Shares of Enhabit stock opened at $7.41 on Tuesday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The business’s 50 day moving average price is $7.52 and its 200 day moving average price is $8.42. The company has a market cap of $372.69 million, a price-to-earnings ratio of -3.19 and a beta of 1.84. Enhabit has a one year low of $6.85 and a one year high of $11.74.

Enhabit (NYSE:EHAB) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The company had revenue of $253.60 million for the quarter, compared to analysts’ expectations of $261.69 million. During the same quarter in the prior year, the firm earned $0.03 EPS. On average, research analysts predict that Enhabit will post 0.25 EPS for the current year.

Institutional Trading of Enhabit

Hedge funds and other institutional investors have recently made changes to their positions in the company. FMR LLC increased its position in shares of Enhabit by 138.4% during the 3rd quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after purchasing an additional 1,967 shares during the last quarter. Gladius Capital Management LP acquired a new stake in shares of Enhabit during the second quarter valued at about $31,000. Quarry LP raised its stake in shares of Enhabit by 242.2% in the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock valued at $33,000 after acquiring an additional 2,621 shares during the period. Allspring Global Investments Holdings LLC purchased a new stake in shares of Enhabit in the 1st quarter valued at approximately $44,000. Finally, ProShare Advisors LLC acquired a new position in shares of Enhabit in the 1st quarter worth approximately $118,000.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.